Emcure Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/11/2026 ,inter alia, to consider and approve Unaudited Financial Results (Standalone and Consolidated) for the quarter and half-year ended September 30, 2026

Emcure Ref: EPL/CS/SE/0090/2026 Date: October 14, 2026 National Stock Exchange of India Limited BSE Limited Exchange Plaza, C-1, Block G, P J Towers, Bandra Kurla Complex, Bandra (East), Dalal Street, Mumbai – 400 051 Mumbai- 400 001 Script Symbol: EMCURE Scrip Code/Symbol: 544210/ EMCURE Dear Sir/Madam, Subject: Board Meeting intimation for approval of Unaudited Financial Results (Standalone and Consolidated) for the quarter and half-year ended September 30, 2026 Pursuant to Regulation 29 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, we wish to inform that a meeting of the Board of Directors of the Company is scheduled to be held on Tuesday, November 03, 2026 inter-alia to consider and approve the Unaudited Financial Results (Standalone and Consolidated) for the quarter and half-ended September 30, 2026. The trading window for dealing in securities of the Company by the Designated Persons and their relatives has been already closed from October 01, 2026, as communicated earlier vide our letter No. EPL/CS/SE/0086/2026 dated September 29, 2026 and shall remain closed till 48 hours after the declaration of the Unaudited Financial Results i.e. till November 05, 2026, in terms of the Company’s Code of Conduct for regulating, monitoring and reporting of insider trading in the securities of the Company, framed pursuant to the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015, as amended. You are requested to take the above information on your records. Thanking you, For Emcure Pharmaceuticals Limited Amruta Yangalwar Company Secretary & Compliance Officer ICSI Membership Number: A25687 Emcure Pharmaceuticals Limited Registered Office: Plot No. P-1 & P-2, IT-BT Park, Phase-II, M.I.D.C., Hinjawadi, Pune - 411057, Maharashtra, India Phone Nos.: +91 20 – 35070033/ 35070000 Fax No.: +91 20 3507 0060 E-mail: corporate@emcure.com Website: www.emcure.com CIN: L24231PN1981PLC024251